Janux Therapeutics Statistics
Total Valuation
JANX has a market cap or net worth of $1.49 billion. The enterprise value is $518.48 million.
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025, after market close.
Earnings Date | May 20, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
JANX has 59.17 million shares outstanding. The number of shares has increased by 22.12% in one year.
Current Share Class | 59.17M |
Shares Outstanding | 59.17M |
Shares Change (YoY) | +22.12% |
Shares Change (QoQ) | +4.03% |
Owned by Insiders (%) | 6.63% |
Owned by Institutions (%) | 84.39% |
Float | 37.48M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 130.47 |
Forward PS | 851.89 |
PB Ratio | 1.48 |
P/TBV Ratio | 1.49 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 48.97 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 59.21, with a Debt / Equity ratio of 0.02.
Current Ratio | 59.21 |
Quick Ratio | 59.03 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -10.09% and return on invested capital (ROIC) is -8.73%.
Return on Equity (ROE) | -10.09% |
Return on Assets (ROA) | -8.57% |
Return on Invested Capital (ROIC) | -8.73% |
Return on Capital Employed (ROCE) | -9.47% |
Revenue Per Employee | $130,716 |
Profits Per Employee | -$851,778 |
Employee Count | 81 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.68% in the last 52 weeks. The beta is 3.24, so JANX's price volatility has been higher than the market average.
Beta (5Y) | 3.24 |
52-Week Price Change | -58.68% |
50-Day Moving Average | 29.81 |
200-Day Moving Average | 42.97 |
Relative Strength Index (RSI) | 36.48 |
Average Volume (20 Days) | 1,067,363 |
Short Selling Information
The latest short interest is 9.34 million, so 15.79% of the outstanding shares have been sold short.
Short Interest | 9.34M |
Short Previous Month | 10.10M |
Short % of Shares Out | 15.79% |
Short % of Float | 24.92% |
Short Ratio (days to cover) | 9.26 |
Income Statement
In the last 12 months, JANX had revenue of $10.59 million and -$68.99 million in losses. Loss per share was -$1.28.
Revenue | 10.59M |
Gross Profit | -57.80M |
Operating Income | -98.85M |
Pretax Income | -44.05M |
Net Income | -68.99M |
EBITDA | -96.79M |
EBIT | -98.85M |
Loss Per Share | -$1.28 |
Full Income Statement Balance Sheet
The company has $1.03 billion in cash and $23.03 million in debt, giving a net cash position of $1.00 billion or $16.94 per share.
Cash & Cash Equivalents | 1.03B |
Total Debt | 23.03M |
Net Cash | 1.00B |
Net Cash Per Share | $16.94 |
Equity (Book Value) | 1.02B |
Book Value Per Share | 17.32 |
Working Capital | 1.02B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$43.81 million and capital expenditures -$359,000, giving a free cash flow of -$44.17 million.
Operating Cash Flow | -43.81M |
Capital Expenditures | -359,000 |
Free Cash Flow | -44.17M |
FCF Per Share | -$0.75 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -933.58% |
Pretax Margin | -651.62% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
JANX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.12% |
Shareholder Yield | -22.12% |
Earnings Yield | -4.54% |
FCF Yield | -2.90% |
Analyst Forecast
The average price target for JANX is $94.29, which is 273.72% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $94.29 |
Price Target Difference | 273.72% |
Analyst Consensus | Strong Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | 105.85% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
JANX has an Altman Z-Score of 34.14 and a Piotroski F-Score of 3.
Altman Z-Score | 34.14 |
Piotroski F-Score | 3 |